Kuala Lumpur, 27 July 2024 – Alhaya Fertility Centre, the newest addition to the Alpha IVF Group family, celebrated its grand opening today with a ceremony graced by Her Royal Highness Tengku Ampuan of Pahang, a passionate advocate in the field of IVF. The event was further enlivened by a special live performance from Malaysia's beloved singer, Siti Nurhaliza, who has successfully delivered two beautiful children, Siti Aafiyah and Muhammad Afwa, through her IVF treatment at Alpha IVF, the sister company of Alhaya Fertility Centre.
The inauguration marks a significant milestone for Alpha IVF Group, underscoring its commitment to providing exceptional fertility care to a diverse and growing community. Alhaya Fertility Centre is thoughtfully designed to embrace diverse cultural backgrounds, ensuring an inclusive environment for all individuals seeking fertility treatments, including the muslim community. The centre is dedicated to enabling every couple to realize their potential for parenthood by offering cutting-edge fertility treatments and resources including the latest application using Artificial Intelligence to increase implantation and In Vitro Activation (IVA) for female with low egg reserve.
Dato' Dr. Colin Lee, Group Managing Director of Alpha IVF Group, stated, "Our mission has always been clear: to enable every couple to fully realize their potential for parenthood. Our strategy, anchored in excellence, innovation, quality, and integrity, has brought us numerous world-first achievements in fertility care. With the grand opening of Alhaya Fertility Centre, we are deepening our commitment to delivering top-notch fertility treatments by expanding our physical footprint to a wider community."
Alpha IVF Group has accumulated more than 20 world-first breakthrough fertility achievements. Recently, one of its centres, Alpha IVF in Kota Damansara, achieved the world's first successful delivery for a couple with a TBCD gene mutation via IVF with PGTA and PGTM, as reported during the Preimplantation Genetic Diagnosis International Society (PGDIS) Congress in May 2024. The group's advancements in Artificial Intelligence were also highlighted during the congress, where Dr. Colin Lee delivered the speech on AI applications in IVF.
Dr. Haris Hamzah, Medical Director of Alhaya Fertility Centre, added, "Alhaya is more than just a fertility clinic; it is a beacon of hope for couples aspiring to start a family. We have already achieved remarkable results, with a fertilization rate of 81.1% and a blastulation rate of 75.1%. We are really enthusiastic about educating and creating awareness about the possibilities of creating new life through the advanced fertility treatments that we are deploying at Alhaya.
The grand opening ceremony was attended by esteemed guests from local and overseas, including Malaysia Healthcare Travel Council (MHTC), doctors and management team from KPJ Healthcare Group and featured a special performance by Siti Nurhaliza, who performed a heartfelt rendition of a song to celebrate the occasion. The event was further highlighted as Alhaya sponsored infertility treatment for three couples from TAFF (Tunku Azizah Fertility Foundation). Dr. Haris Hamzah symbolically presented a placard representing the sponsorship to Her Majesty, the Queen of Pahang.
Alhaya Fertility Centre boasts the latest advanced fertility technology, including Artificial Intelligence, Cryotec freezing that achieves a 100% embryo survival rate, and IVA (in vitro activation) to rejuvenate ovaries, all aimed at optimizing patients' success rates.
The public listing of Alpha IVF Group in March 2024 has further strengthened its financial position, allowing for the expansion of services and reaching more people in need. Alhaya Fertility Centre is the first addition to the family post-IPO, with many exciting plans on the horizon.
With its dedication to advanced technologies, innovative treatment protocols, and skilled medical professionals, Alpha IVF Group continues to lead the way in fertility care, delivering the best possible outcomes for patients and pushing the boundaries of reproductive medicine.
